203 related articles for article (PubMed ID: 34838668)
1. Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.
Gonzalez S; McHugh TLM; Yang T; Syriani W; Massa SM; Longo FM; Simmons DA
Neurobiol Dis; 2022 Jan; 162():105563. PubMed ID: 34838668
[TBL] [Abstract][Full Text] [Related]
2. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
[TBL] [Abstract][Full Text] [Related]
3. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.
Simmons DA; Knowles JK; Belichenko NP; Banerjee G; Finkle C; Massa SM; Longo FM
PLoS One; 2014; 9(8):e102136. PubMed ID: 25153701
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.
Salehi A; Verhaagen J; Dijkhuizen PA; Swaab DF
Neuroscience; 1996 Nov; 75(2):373-87. PubMed ID: 8931004
[TBL] [Abstract][Full Text] [Related]
5. A small molecule TrkB/TrkC neurotrophin receptor co-activator with distinctive effects on neuronal survival and process outgrowth.
Yang T; Massa SM; Tran KC; Simmons DA; Rajadas J; Zeng AY; Jang T; Carsanaro S; Longo FM
Neuropharmacology; 2016 Nov; 110(Pt A):343-361. PubMed ID: 27334657
[TBL] [Abstract][Full Text] [Related]
6. A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model.
Latif-Hernandez A; Yang T; Raymond-Butler R; Losada PM; Minhas PS; White H; Tran KC; Liu H; Simmons DA; Langness V; Andreasson KI; Wyss-Coray T; Longo FM
Alzheimers Dement; 2024 May; ():. PubMed ID: 38779814
[TBL] [Abstract][Full Text] [Related]
7. ProNGF and Neurodegeneration in Alzheimer's Disease.
Fahnestock M; Shekari A
Front Neurosci; 2019; 13():129. PubMed ID: 30853882
[TBL] [Abstract][Full Text] [Related]
8. Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease.
Kwakowsky A; Milne MR; Waldvogel HJ; Faull RL
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999310
[TBL] [Abstract][Full Text] [Related]
9. Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model.
Knowles JK; Simmons DA; Nguyen TV; Vander Griend L; Xie Y; Zhang H; Yang T; Pollak J; Chang T; Arancio O; Buckwalter MS; Wyss-Coray T; Massa SM; Longo FM
Neurobiol Aging; 2013 Aug; 34(8):2052-63. PubMed ID: 23545424
[TBL] [Abstract][Full Text] [Related]
10. Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons.
Allard S; Jacobs ML; Do Carmo S; Cuello AC
Neurobiol Aging; 2018 Jul; 67():10-20. PubMed ID: 29609077
[TBL] [Abstract][Full Text] [Related]
11. Estradiol modulation of neurotrophin receptor expression in female mouse basal forebrain cholinergic neurons in vivo.
Milne MR; Haug CA; Ábrahám IM; Kwakowsky A
Endocrinology; 2015 Feb; 156(2):613-26. PubMed ID: 25415243
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
Counts SE; Che S; Ginsberg SD; Mufson EJ
J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration.
Xie Y; Meeker RB; Massa SM; Longo FM
Sci Rep; 2019 Mar; 9(1):5273. PubMed ID: 30918278
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
15. The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic Atrophy.
Do Carmo S; Kannel B; Cuello AC
Cells; 2021 Dec; 11(1):. PubMed ID: 35011577
[TBL] [Abstract][Full Text] [Related]
16. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
17. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
Ubhi K; Rockenstein E; Vazquez-Roque R; Mante M; Inglis C; Patrick C; Adame A; Fahnestock M; Doppler E; Novak P; Moessler H; Masliah E
J Neurosci Res; 2013 Feb; 91(2):167-77. PubMed ID: 23152192
[TBL] [Abstract][Full Text] [Related]
18. The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo.
Knowles JK; Rajadas J; Nguyen TV; Yang T; LeMieux MC; Vander Griend L; Ishikawa C; Massa SM; Wyss-Coray T; Longo FM
J Neurosci; 2009 Aug; 29(34):10627-37. PubMed ID: 19710315
[TBL] [Abstract][Full Text] [Related]
19. The cholinergic system, nerve growth factor and the cytoskeleton.
Niewiadomska G; Mietelska-Porowska A; Mazurkiewicz M
Behav Brain Res; 2011 Aug; 221(2):515-26. PubMed ID: 20170684
[TBL] [Abstract][Full Text] [Related]
20. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
Triaca V; Ruberti F; Canu N
Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
